Insider · CIK 0001376355

Lichter Jay

Reports to the SEC for 5 companies · KANSAS CITY, KS

sec.gov

Transactions

Companies

Filings

CIK

0001376355

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-13	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−391 sh	—	—	7,682
2024-09-13	JANXJanux Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1,868 sh	$17.00	+$31.8K	8,868
2024-09-13	JANXJanux Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+778 sh	$10.73	+$8,347.94	9,646
2024-09-13	JANXJanux Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+778 sh	$13.22	+$10.3K	10,424
2024-09-13	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−778 sh	—	—	11,308
2024-09-13	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−778 sh	—	—	11,308
2024-09-13	JANXJanux Therapeutics, Inc.M Exercise/Conversion	10% Owner	MExercise/Conversion	+391 sh	$39.80	+$15.6K	10,815
2024-09-13	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−1,868 sh	—	—	27,138
2024-09-13	JANXJanux Therapeutics, Inc.S Sale	10% Owner	SSale	−3,815 sh	$46.68	−$178K	7,000
2024-06-26	JANXJanux Therapeutics, Inc.A Award	10% Owner	AAward	+2,500 sh	—	—	7,083
2024-06-26	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	10% Owner	AAward	+8,350 sh	—	—	8,350
2024-06-03	JANXJanux Therapeutics, Inc.S Sale	10% Owner	SSale	−677K sh	$54.75	−$37.1M	3,271,216
2024-06-03	JANXJanux Therapeutics, Inc.S Sale	10% Owner	SSale	−131K sh	$54.75	−$7.18M	633,673
2024-06-03	JANXJanux Therapeutics, Inc.S Sale	10% Owner	SSale	−692K sh	$54.75	−$37.9M	3,340,018
2023-11-13	JANXJanux Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+850K sh	$5.87	+$4.99M	849,854
2023-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	10% Owner	AAward	+12.5K sh	—	—	12,500
2022-06-21	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2022-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	10% Owner	AAward	+12.5K sh	—	—	12,500
2021-06-22	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	10% Owner	CConversion	+674K sh	—	—	4,387,217
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.38M sh	—	—	3,713,006
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.14M sh	—	—	1,330,815
2021-06-15	JANXJanux Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−900K sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.11M sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−526K sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc. · Series Seed 2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.86M sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc. · Series Seed Convertible Preferred StockC Conversion	10% Owner	CConversion	−889K sh	—	—	0
2021-06-15	JANXJanux Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+629K sh	$17.00	+$10.7M	4,479,492
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.15M sh	—	—	3,850,081
2021-06-15	JANXJanux Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.7M sh	—	—	2,696,843
2021-06-10	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	10% Owner	AAward	+30K sh	—	—	30,000
2021-03-03	OTONOMY, INC.S Sale	Director	SSale	−114K sh	$2.70	−$307K	0
2021-03-03	OTONOMY, INC.S Sale	Director	SSale	−207K sh	$2.70	−$559K	0
2021-03-02	OTONOMY, INC.S Sale	Director	SSale	−251K sh	$2.90	−$729K	207,245
2021-03-02	OTONOMY, INC.S Sale	Director	SSale	−138K sh	$2.90	−$401K	113,935
2021-03-01	OTONOMY, INC.S Sale	Director	SSale	−112K sh	$2.86	−$320K	458,620
2021-03-01	OTONOMY, INC.S Sale	Director	SSale	−61.6K sh	$2.86	−$176K	252,134
2021-02-26	OTONOMY, INC.S Sale	Director	SSale	−213K sh	$2.83	−$604K	570,701
2021-02-26	OTONOMY, INC.S Sale	Director	SSale	−117K sh	$2.83	−$332K	313,753
2021-02-25	OTONOMY, INC.S Sale	Director	SSale	−110K sh	$2.95	−$326K	431,015
2021-02-25	OTONOMY, INC.S Sale	Director	SSale	−201K sh	$2.95	−$593K	783,993
2021-02-24	OTONOMY, INC.S Sale	Director	SSale	−178K sh	$2.98	−$532K	541,376
2021-02-24	OTONOMY, INC.S Sale	Director	SSale	−325K sh	$2.98	−$968K	984,732
2021-02-23	OTONOMY, INC.S Sale	Director	SSale	−173K sh	$2.89	−$500K	1,309,383
2021-02-23	OTONOMY, INC.S Sale	Director	SSale	−95.1K sh	$2.89	−$275K	719,860
2020-06-23	OTONOMY, INC.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-01-23	Synthorx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.3K sh	$55.60	−$853K	0
2020-01-23	Synthorx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	$57.00	−$1.71M	0
2020-01-23	Synthorx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1.68M sh	$68.00	−$114M	0
2020-01-23	Synthorx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−449K sh	$68.00	−$30.5M	0

Recent filings

Accepted (ET)
Oct 244
Lichter Jay0001415889-24-025601
SEC(opens sec.gov)
Jun 284
Lichter Jay0001415889-24-018443
SEC(opens sec.gov)
Jun 54
Lichter Jay0001415889-24-015678
SEC(opens sec.gov)
Nov 154
Lichter Jay0001209191-23-055349
SEC(opens sec.gov)
Jun 164
Lichter Jay0001209191-23-037989
SEC(opens sec.gov)
Jun 234
Lichter Jay0001209191-22-038889
SEC(opens sec.gov)
Jun 164
Lichter Jay0001209191-22-037428
SEC(opens sec.gov)
Jun 244
Lichter Jay0001209191-21-043073
SEC(opens sec.gov)
Jun 164
Lichter Jay0001209191-21-041038
SEC(opens sec.gov)

Companies

Address

C/O ARATANA THERAPEUTICS, INC. 1901 OLATHE BOULEVARD

KANSAS CITY, KS, 66103